We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blind Gain Sight in Gene Therapy Trial

News   Oct 08, 2018 | Original story from the University of Oxford

 
Gene Therapy Trial a Success in Treating Rare Form of Blindness

Photo credit: Pixabay

 
 
 

RELATED ARTICLES

RNA Folding Insights Lead to New Therapeutics and Synthetic Biology Technologies

News

A research team has uncovered a new understanding of how RNA molecules act as cellular "biosensors" to monitor and respond to changes in the environment by controlling gene expression.

READ MORE

British Columbia’s HPV Vaccination Program Reduces Cervical Pre-cancer Rates by > 50%

News

British Columbia’s school-based human papillomavirus (HPV) immunization program is reducing rates of cervical pre-cancer in B.C. women, according to a new study.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE